Professor Mark Lawler brings significant expertise and international standing to the board in digital health, precision medicine and inequalities research. He leads a number of major international initiatives including Health Data Research UK’s Big Data for Complex Disease Driver Programme, the International Cancer Benchmarking Partnership and the Lancet Oncology European Groundshot.

Mark also co-leads two all island initiatives in precision medicine and digital health and currently serves on the board of the National Cancer Registry of Ireland.